Cytoreductive Surgery for Peritoneal Malignancies-Development of Standards of Care for the Community

Surgical Oncology Clinics of North America

Volumn 16, Issue 3, 2007, Pages 653-666

  Esquivel, Jesus ^a  

^a ST AGNES HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; MITOMYCIN; OXALIPLATIN;

CANCER CHEMOTHERAPY; CARCINOMATOUS PERITONITIS; CLINICAL TRIAL; COLON CANCER; CYTOREDUCTIVE SURGERY; HUMAN; MALIGNANT TRANSFORMATION; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PERITONEUM CANCER; PROGNOSIS; QUALITY OF LIFE; REVIEW; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; HUMANS; HYPERTHERMIA, INDUCED; LAPAROSCOPY; PERITONEAL NEOPLASMS; PROGNOSIS; QUALITY OF LIFE;

EID: 34250825507     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2007.04.015     Document Type: Review

References (29)

1. Hurwitz H.I., Fehrenbacher L., Hainsworth J.D., et al. Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer. J Clin Oncol 23 (2005) 3502-3508
2. Sadeghi B., Arvieux C., Glehen O., et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88 (2000) 58-63
3. Esquivel J., and Sugarbaker P.H. Clinical presentation of the Pseudomyxoma peritonei syndrome. Br J Surg 87 (2000) 1414-1418
4. Zoetmulder F. Cancer cell seeding during abdominal surgery: experimental studies. In: Sugarbaker P.H. (Ed). Peritoneal carcinomatosis: principles of management (1996), Kluwer Academic Publishers, Boston 155-161
5. Sugarbaker P.H. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome. Lancet Oncol 7 (2006) 69-76
6. Sugarbaker P.H., Graves T., DeBruijn E.A., et al. Rationale for early post-operative intraperitoneal chemotherapy (EPIC) in patients with advanced gastrointestinal cancer. Cancer Res 50 (1990) 5790-5794
7. Look M., Chang D., and Sugarbaker P.H. Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum. Int J Gynecol Cancer 14 (2004) 35-41
8. Katz M.H., and Barone R.M. The rationale of perioperative intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies. Surg Oncol Clin N Am 12 (2003) 673-688
9. Sugarbaker P.H., Yan T.D., Stuart O.A., et al. Comprehensive management of diffuse malignant peritoneal mesothelioma. Eur J Surg Oncol 32 (2006) 686-691
10. Verwaal V.J., van Tinteren H., van Ruth S., et al. Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. Br J Surg 91 (2004) 739-746
11. Sugarbaker P.H. Peritonectomy procedures. Ann Surg 221 (1995) 29-42
12. Glehen O., Cotte E., Schreiber V., et al. Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin. Br J Surg 91 (2004) 747-754
13. Carmignani C.P., Ortega-Perez G., and Sugarbaker P.H. The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer. Eur J Surg Oncol 30 (2004) 391-398
14. Elias D., Delperro J.R., Sideris L., et al. Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials. Ann Surg Oncol 11 (2004) 518-521
15. Elias D, Raynard B, Farkhondeh F, et al. Peritoneal carcinomatosis of colorectal origin: long-term results of intraperitoneal chemohyperthermia with oxaliplatin following complete cytoreductive surgery. Gastroenterol Clin Biol, in press.
16. Verwaal V.J., van Ruth S., de Bree E., et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal origin. J Clin Oncol 21 (2003) 3737-3743
17. Glehen O., Kwiatkowski F., Sugarbaker P.H., et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22 (2004) 3284-3292
18. Yan TD, Black D, Savady R, et al. A systemic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 2006;24:4011-9.
19. Esquivel J., Sticca R., Sugarbaker P.H., et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Ann Surg Oncol 14 1 (2007) 128-133
20. de Bree E., Koops W., Kroger R., et al. Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol (2005)
21. Yan T.D., Haveric N., Carmignani C.P., et al. Computed tomographic characterization of malignant peritoneal mesothelioma. Tumori 91 (2005) 394-400
22. Garofalo A., and Valle M. [Staging videolaparoscopy of peritoneal carcinomatosis]. Tumori 89 4 Suppl (2003) 70-77 [Italian]
23. Pomel C., Appleyard T.L., Gouy S., et al. The role of laparoscopy to evaluate candidates for complete cytoreduction of peritoneal carcinomatosis and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 31 5 (2005) 540-543
24. Sugarbaker P.H., and Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6 (1999) 727-731
25. O'Connell J.T., Tomlinson J.S., Roberts A.A., et al. Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells. Am J Pathol 161 (2002) 551-564
26. Sugarbaker P.H. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 43 Suppl (1999) S15-S25
27. Sugarbaker P.H., Alderman R., Edwards G., et al. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol 13 (2006) 1-11
28. McQuellon R.P., Loggie B.W., Fleming R.A., et al. Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis. Eur J Surg Oncol 27 (2001) 65-73
29. McQuellon R.P., Loggie B.W., Lehman A.B., et al. Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol 10 (2003) 155-162